Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose Disorders Induced by Tacrolimus in Pre-Transplant End-Stage Renal Disease Patients
2018-001024-19Phase 4Active
- Sponsor
- CHD Vendée
- Start
- Jun 2018
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus in end-stage kidney disease (ESKD), sponsored by CHD Vendée. Started Jun 2018; status: active.
02
Drugs
tacrolimus
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2018-001024-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001024-19.